
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Dinshaw J. Patel discloses the following relationships and financial interests:
-
Aduro Biotech, Inc
Intellectual Property Rights -
Ankrin Therapeutics
Intellectual Property Rights -
Arrakis Therapeutics
Provision of Services -
CheerLand Investment Group
Provision of Services -
China Nucleic Acids Forum
Provision of Services -
Chinese Academy of Sciences
Provision of Services -
Fudan University
Provision of Services -
Harbin Institute of Technology, Harbon, China
Provision of Services -
Institute of Biophysics, Chinese Academy of Sciences
Provision of Services -
Nankai University
Provision of Services
-
Shanghai Jiao Tong University School of Medicine
Provision of Services -
Shenzhen Bay Laboratory
Provision of Services -
Southern University of Science and Technology
Provision of Services -
Southwest University, Chongqing
Provision of Services -
Takeda Pharmaceuticals
Intellectual Property Rights -
Tsinghua University
Provision of Services -
University of Science and Technology of China
Provision of Services -
Westlake University
Provision of Services -
Wuhan Institute of Virology
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures